Hip Infection
3
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Not Silver Coated Device
Research Leaders
5 sponsors active, led by Istituto Ortopedico Rizzoli
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections
Relationship Between Preoperative Subcutaneous Trochanteric Fat Thickness and Postoperative Infection Risk
Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
Research Network
Common Treatments
- Not Silver Coated Device1
- Implantation Of An Articulating Spacer1
- Silver Coated Device1
- Implantation Of A Static Nonarticulating Cement Spacer1
Active Sponsors
- Istituto Ortopedico Rizzoli1
- Thomas Jefferson University1
- Ankara City Hospital Bilkent1
- Rush University Medical Center1
- Central DuPage Hospital1
Top Investigators
Rush University Medical Center
Thomas Jefferson Hospital
Rush University Medical Center
Thomas Jefferson Hospital
Rush University Medical Center
Related Conditions
- Complications Arthroplasty Infection Or Inflammation1
- Complications Arthroplasty1
- Prosthetic Joint Infection1
- Osteoarthritis1